Lot of after hours action. Like a lot. Nothing would surprise me. What I will tell you, which I'm sure you already know, is that avxl more than tripled after July 22 results before settling into a 125 percent gain. Now that was with 12 patients. Now we have top line for all 32 patients for the 36 days. We also have data for Part B. I'm guessing we have data from at least 12 for 26 weeks. So the upcoming data will be more robust and telling. Now as to what is currently priced in? I don't know. But additional great results could bring your 5 buck flips.